Philippe Marchand - 31 Mar 2022 Form 4 Insider Report for BIOCEPT INC

Reporting relationship: Chief Operations Officer
Issuer ticker: N/A
Reported as of: 31 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Apr 2022, 14:24:56 UTC
Prior SEC filing: 16 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Philippe Marchand

Key filing fact

Philippe Marchand filed Form 4 for BIOCEPT INC on 04 Apr 2022.

Key facts

This page summarizes Philippe Marchand's Form 4 filing for BIOCEPT INC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Apr 2022, 14:24.

Change

Previous filing in this sequence was filed on 16 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIOC transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +150,000
Change %
Price: $0.000000
Shares after: 150,000
Date: 31 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $2.32
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to the option shall vest on the first anniversary of March 7, 2022 with the balance vesting in equal monthly installments until fully vested on March 7, 2026.